# Humane Genomics

**Canonical:** https://apis.io/providers/humane-genomics/  
**Website:** https://humanegenomics.com  
**APIs profiled:** 0

Humane Genomics Inc is a New York City biotechnology company engineering oncolytic RNA viruses to selectively target and destroy cancer cells. Using a first-principle, computer-aided design approach built on Vesicular Stomatitis Virus (VSV) with aptazyme-controlled selective replication, the company develops precision viral therapies; its lead candidate targets pediatric liver cancer (hepatoblastoma). Backed by Union Square Ventures, Humane Genomics operates from Alexandria LaunchLabs and partners with Genezen for cGMP manufacturing. The company publishes no public API or developer surface; this API Evangelist profile tracks it as a portfolio-company lead.

## Kin Score — 5.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 5.5).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Humane Genomics Domain Security** — TLSv1.3

## Tags

Company, Biotechnology, Genomics, Oncology, Therapeutics, Cancer, Synthetic Biology

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/humane-genomics/). Scores are computed from the provider's own public artifacts under a published rubric.